Clinical Research Fellowship 2025 Cohort


Isla Leslie

Isla Leslie

Project title - Exploring the efficacy of a PARP inhibitor and Oncolytic virus and the effects on the immune microenvironment in triple negative breast cancer.

Why did you choose this project and how will it impact cancer patients? 

 

As a clinician I witnessed first-hand the transformative effects of immunotherapy on difficult to treat cancers, achieving the possibility of a "cure" for metastatic cancer. This inspired me to go into research to understand immune- tumour interactions further and test new immune-based therapies.

 

I hope that this will impact cancer patients by providing new treatments to patients who would not have had access to immunotherapy as well as expanding the use of oncolytic viruses which are an exciting treatment modality.

 


Interesting fact about yourself

I was the U16s Haggis eating champion.